Author

Z. Raviv

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Y. Shaked· 2 shared B. James· 1 shared C. Carrere· 1 shared E. Pasquier· 1 shared G. Chapuisat· 1 shared K. Klever· 1 shared K. Magidey-Klein· 1 shared M. Bondarenko· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Y. Shaked

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Metronomic therapy prevents emergence of drug resistance by maintaining the dynamic of intratumor heterogeneity.

M. Bondarenko, M. Le Grand, Y. Shaked, Z. Raviv, G. Chapuisat, C. Carrere, M.-P. Montero, M. Rossi, E. Pasquier, M. Carre, N. Andre

This study shows metronomic therapy better controls tumor heterogeneity than maximum-tolerated dose by leveraging drug-sensitive clones' suppressive effect on resistant ones through paracrine mechanisms.

bioRxiv · Jan 4, 2021 · PreprintCancer Biology

Tumor-educated monocyte-dendritic progenitors promote a metastatic switch

K. Magidey-Klein, K. Klever, T. J. Cooper, R. Normand, T. Zhang, M. Timaner, Z. Raviv, B. James, R. Gazit, Z. A. Ronai, S. S. Shen-Orr, Y. Shaked

The paper shows that metastatic tumors drive HSPCs to differentiate into monocyte-dendritic progenitors via IL-6, promoting metastasis.

bioRxiv · Aug 25, 2020 · PreprintCancer Biology